<html>

        <head>
        <link href="../style1.css" rel="stylesheet" type="text/css">
        </head>
        <table border = 1>
        <tr>
        <th>PubMedID</th>
        <th>Sentence</th>
        <th>First Gene</th>
        <th>Second Gene</th>
        <th>Interaction</th>
        </tr>
        <body>
<tr class = "cellcolor">
<td>24277232</td>
<td>This tumour entity is currently assessed by immunohistochemistry (IHC) detecting "general" NE markers such as chromogranin A (CHGA) and synaptophysin (SYP), but other markers  have been considered as well</td>
<td>CHGA</td>
<td>SYP</td>
<td>Neutral</td>
</tr>
<tr class = "cellcolor">
<td>24277232</td>
<td>In the present study, in addition to CHGA and SYP,  we investigated the expression of VGF, a neurotrophin-inducible gene, which is emerging as a new specific NE marker</td>
<td>CHGA</td>
<td>SYP</td>
<td>Neutral</td>
</tr>
<tr class = "cellcolor">
<td>24277232</td>
<td>Over-expression of one or more NE marker (CHGA and/or SYP and/or VGF) characterizes a significant fraction (approximately 10Â %) of infiltrative breast  cancers.</td>
<td>CHGA</td>
<td>SYP</td>
<td>Neutral</td>
</tr>
